Starting Today: Effects of a Preventive Treatment Initiated During a Migraine Attack
Adams B/C
Industry Event
Information
Industry-Sponsored Event
Sponsored by Lundbeck Pharmaceuticals
Not Eligible for CME Credits Dawn C. Buse, PhD, FAHS Albert Einstein College of Medicine Rami Apelian, MD, MPH, FAES Huntington Headache & Neurology Paul K. Winner, DO, FAAN, FAAP, FAHS Palm Beach Headache Center
In this symposium, leading experts discuss the clinical impact and potential burden associated with migraine, as well as the effects of a preventive anti-CGRP monoclonal antibody when initiated during a migraine attack.
